Results 11 to 20 of about 317,416 (245)

A Multifaceted Approach to Treatment of Recalcitrant Cutaneous Periorbital Juvenile Xanthogranuloma. [PDF]

open access: yesJ Ophthalmic Vis Res, 2023
Purpose To demonstrate novel treatments for patients with high juvenile xanthogranuloma (JXG) eyelid lesion burden. Case Report A 14-year-old girl was referred to the oculoplastic surgery service for management of worsening extensive bilateral eyelid and
Van Brummen A   +4 more
europepmc   +5 more sources

Case of compressive myelopathy due to juvenile xanthogranuloma of cervicothoracic junction in a 28-year-old male. [PDF]

open access: yesSurg Neurol Int, 2023
Background: Juvenile xanthogranuloma (JXG) is a proliferative disorder of non-Langerhans histiocytes. The lesions typically occur in children as solitary cutaneous lesions, but are only rarely found in adults in their late twenties to thirties ...
Baskoro W   +6 more
europepmc   +5 more sources

Frequent detection of genetic aberrations reveals novel pathogenesis and treatment modalities in systemic juvenile xanthogranuloma. [PDF]

open access: yesPediatr Investig, 2023
Juvenile xanthogranuloma (JXG), the most common form of non-Langerhans cell histiocytosis (non-LCH), is generally confined to the skin during infancy and early childhood.1 JXG rarely involves extracutaneous tissues or systemic organs, resulting in high ...
Xu J   +7 more
europepmc   +2 more sources

Neuroimaging in Pediatric Patients with Juvenile Xanthogranuloma of the CNS. [PDF]

open access: yesAJNR Am J Neuroradiol, 2022
BACKGROUND AND PURPOSE: Juvenile xanthogranuloma is a rare clonal, myeloid, neoplastic disorder. Typically, juvenile xanthogranuloma is a self-limited disorder of infancy, often presenting as a solitary red-brown or yellow skin papule/nodule.
Serrallach BL   +11 more
europepmc   +2 more sources

Disseminated Juvenile Xanthogranuloma with a Novel MYH9-FLT3 Fusion Presenting as a Blueberry Muffin Rash in a Neonate. [PDF]

open access: yesAJP Rep, 2023
Juvenile xanthogranuloma (JXG) is a benign proliferative histiocytic disorder of the dendritic cell phenotype. It mostly presents in the pediatric age group as a solitary skin lesion.
Clark EE   +5 more
europepmc   +2 more sources

Congenital Giant Juvenile Xanthogranuloma, Let It Be. [PDF]

open access: yesHCA Healthc J Med, 2022
Description Juvenile xanthogranuloma (JXG) is a rare type of non-Langerhans cell histiocytosis. JXGs are benign and have a self-limiting course generally lasting 6 months to 3 years, with some reported durations longer than 6 years.
Carletti M, Nguyen DA, Susa JS, Weis SE.
europepmc   +2 more sources

Imaging features of neonatal systemic juvenile xanthogranuloma: a case report and review of the literature. [PDF]

open access: goldJ Int Med Res, 2020
Juvenile xanthogranuloma (JXG) is the most common non-Langerhans cell histiocytic disorder in children. This report describes the case of a 28-day-old boy that presented with multiple subcutaneous nodular lesions on the trunk and extremities, and ...
He S   +5 more
europepmc   +6 more sources

Solitary juvenile xanthogranuloma of temporal bone: a case report. [PDF]

open access: yesBMC Pediatr, 2022
Background Juvenile xanthogranuloma (JXG) is a kind of non-Langerhans cell histiocytosis, usually with skin lesions as the main manifestation. It rarely occurs in other tissues or organs and even more rarely is it found in the skull.
Wang SN, Lu J.
europepmc   +2 more sources

Juvenile Xanthogranuloma as Differential Diagnosis of a Vulvar Mass: A Case Report. [PDF]

open access: yesEuropean J Pediatr Surg Rep, 2022
Vulvar masses in children are an unusual finding but their differential diagnosis is extensive. In case of solid masses, rhabdomyosarcoma (RMS) must always be considered due to the fact that it is the most common tumor in external genitals during ...
Bada Bosch I   +7 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy